This lack of expression correlates with the DNA hypermethylation of FSP1 promoter in cells and patient biopsies and creates a selective dependency of ALL cells on GSH-dependent ferroptosis defenses. Here, AIFM2 is linked to acute lymphoblastic leukemia.